Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price: 7,380.00
Bid: 7,381.00
Ask: 7,383.00
Change: 56.00 (0.76%)
Spread: 2.00 (0.03%)
Open: 7,355.00
High: 7,402.00
Low: 7,329.00
Yest. Close: 7,324.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

China Approves Expanded Release Of AstraZeneca Anaemia Drug

(Alliance News) - AstraZeneca PLC announced Chinese approval for roxadustat in non-dialysis-dependent patients on Thursday, as well as the USD95 million purchase of a priority review voucher in Co

22 Aug 19 08:36

AstraZeneca granted marketing authorisation for Roxadustat in China

(Sharecast News) - Biopharmaceutical company AstraZeneca has received marketing authorisation for Roxadustat in China for the treatment of anaemia caused by chronic kidney disease in non-dialysis-dependent patients.

22 Aug 19 08:21

LONDON BRIEFING: Johnson Set For Brexit Talks With French President

(Alliance News) - UK Prime Minister Boris Johnson on Thursday is set for showdown Brexit talks in Paris, hours after French President Emmanuel Macron ruled out making concessions.The UK was

22 Aug 19 07:50

LONDON MARKET PRE-OPEN: Buybacks From CRH, Playtech And NMC Health

(Alliance News) - Stocks in London are set to open lower on Thursday after minutes from the US Federal Reserve were less dovish than markets had been anticipating.In early UK company news,

22 Aug 19 07:33

TOP NEWS: AstraZeneca Drug Fails To Improve Survival In Neptune Trial

(Alliance News) - AstraZeneca PLC on Wednesday said its phase 3 Neptune trial of Imfinzi in combination with tremelimumab did not meet its primary endpoint of improving overall was a randomised, a

21 Aug 19 07:46

LONDON MARKET PRE-OPEN: Inchcape And Hammerson Hire New CFOs

(Alliance News) - Stocks in London are set to open on a cautious note on Wednesday ahead of the US Federal Reserve releasing minutes from its latest monetary policy meeting.In early UK company a a

21 Aug 19 07:40

AstraZeneca drug fails to improve on chemotherapy in lung cancer trial

(Sharecast News) - AstraZeneca confirmed on Wednesday that its Imfinzi (durvalumab) treatment for lung and bladder cancer failed to improve upon survival rates registered by chemotherapy treatment in a clinical trial where it was combined with a human monoclonal antibody.

21 Aug 19 07:22

LONDON MARKET MIDDAY: Stocks Extend Gains On Improved Risk Appetite

(Alliance News) - London stocks were building on recent gains on Tuesday as the previous session's optimism over US-China trade talks and German economic stimulus flowed into a second day. the

20 Aug 19 12:05

WINNERS & LOSERS SUMMARY: BHP Falls After Earnings Miss Expectations

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------J up 2.5%, Group,

20 Aug 19 10:28

LONDON MARKET OPEN: AstraZeneca And BHP Top-And-Tail FTSE 100

(Alliance News) - Stock prices in London opened higher on Tuesday continuing positive momentum from Monday, amid optimism over US-China trade negotiations after the US granted telecom equipment a

20 Aug 19 08:56

Astra's Farxiga Meets Primary Endpoint For Heart Failure Treatment

(Alliance News) - FTSE 100-listed AstraZeneca PLC on Tuesday reported positive results from the third phase of DAPA-HF trial.The drugmaker said the study showed Farxiga met the primary with

20 Aug 19 07:46

AstraZeneca upbeat on latest 'Forxiga' trial outcomes

(Sharecast News) - AstraZeneca announced positive results from its phase 3 'DAPA-HF' trial on Tuesday, which showed that 'Farxiga' (dapagliflozin) met the primary composite endpoint with a statistically-significant and clinically-meaningful reduction of cardiovascular death or worsening of heart failure - defined as hospitalisation or an urgent heart failure visit - compared to placebo.

20 Aug 19 07:27

AstraZeneca Appoints Vodafone Non-Executive Michel Demare To Board

(Alliance News) - AstraZeneca PLC on Monday said it appointed Michel Demare as a non-executive director and a member of the audit committee, with effect from September 1.The drugmaker said

19 Aug 19 08:16

BROKER RATINGS SUMMARY: Morgan Stanley Raises Hiscox To Overweight

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:----------FTSE 100----------MORGAN STANLEY RAISES TO

16 Aug 19 09:31

WINNERS & LOSERS SUMMARY: Sports Direct Sinks After Auditors Hang Back

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - Group, up 5.0%. The insurer reported profit in of

14 Aug 19 10:47

Login to your account

Don't have an account? Click here to register.